John Boyer Inc’s Novo Nordisk NVO Stock Holding History

John Boyer Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.14K	Buy	+30	New	+$1.38K	﹤0.01%	214

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

John Boyer Inc's NVO Position: Q3 2026 in Review

John Boyer Inc opened a new position in Novo Nordisk (NVO) in Q3 2026: 30 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #214 among its holdings.

968 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

John Boyer Inc held 30 shares of Novo Nordisk worth $1.14K as of Q3 2026.
Novo Nordisk was a new John Boyer Inc position in Q3 2026.
Novo Nordisk made up ﹤0.01% of John Boyer Inc's portfolio in Q3 2026, its #214 holding.
968 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on John Boyer Inc's 13F filing for Q3 2026, filed 27 Oct 2026.